Clinical trial
Ductal Carcinoma in Situ: Protocol Evaluating the Assessment of Extension of Disease by MRI
NCT00874458 is registered in ClinicalTrials.gov with Centre Antoine Lacassagne as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ductal Carcinoma in Situ: Protocol Evaluating the Assessment of Extension of Disease by MRI
- Lead sponsor
- Centre Antoine Lacassagne
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 30, 2007
- Completion date
- December 31, 2013
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer